RESI JPM 2024 - Online | Life Science Nation, LLC | 9 January 2024 | Virtual Event

The conference connects start-ups and early-stage investors and strategic channel partners maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. The conference is a uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. A unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development through a match-based partnering system, pitch opportunities, and industry expert panels.